Cargando…
COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series
INTRODUCTION: Coronavirus disease 2019 (COVID‐19) and acquired immune deficiency syndrome (AIDS) are two viral diseases for which there are currently no definitive treatments. Nowadays, because of the health system's focus on the COVID‐19 epidemic, the control of human immunodeficiency virus (H...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993621/ https://www.ncbi.nlm.nih.gov/pubmed/35187723 http://dx.doi.org/10.1002/jcla.24308 |
_version_ | 1784683936912244736 |
---|---|
author | Heidary, Mohsen Asadi, Arezoo Noorbakhsh, Negar Dashtbin, Shirin Asadollahi, Parisa Dranbandi, Atieh Navidifar, Tahereh Ghanavati, Roya |
author_facet | Heidary, Mohsen Asadi, Arezoo Noorbakhsh, Negar Dashtbin, Shirin Asadollahi, Parisa Dranbandi, Atieh Navidifar, Tahereh Ghanavati, Roya |
author_sort | Heidary, Mohsen |
collection | PubMed |
description | INTRODUCTION: Coronavirus disease 2019 (COVID‐19) and acquired immune deficiency syndrome (AIDS) are two viral diseases for which there are currently no definitive treatments. Nowadays, because of the health system's focus on the COVID‐19 epidemic, the control of human immunodeficiency virus (HIV) has received less attention. In this review, we will discuss the characteristics of COVID‐19 in HIV‐positive patients. MATERIAL AND METHODS: Using the PRISMA guideline, the databases of Scopus, PubMed, and Web of Science were searched systematically from January 1, 2019 to February 24, 2021. The following keywords were used: “Human Immunodeficiency Virus,” “acquired immune deficiency syndrome,” “HIV,” “AIDS,” “COVID‐19,” “severe acute respiratory syndrome coronavirus 2,” “novel coronavirus,” “SARS‐CoV‐2,” “nCoV disease,” “SARS2,” and “2019‐nCoV disease.” RESULTS: Twenty‐one percent of studies were conducted in the USA (n = 13), 16% in China (n = 10), and 13% in Italy (n = 8), respectively. The majority of the patients were men (74.3%). Tenofovir disoproxil fumarate was used in 47.4% of patients, emtricitabine in 58.4%, and lamivudine in 34.8% to treat HIV. Symptoms of HIV patients with COVID‐19 included coughing (81.3%), fever (62.8%), and dyspnea (60%). Hydroxychloroquine (39.34%) and azithromycin (36.58%) were the common treatment options for COVID‐19. The total death rate in HIV‐positive patients with COVID‐19 was about 9%. CONCLUSION: In the current systematic review, we demonstrated that HIV‐positive patients co‐infected with COVID‐19 have high comorbidity of hypertension and diabetes mellitus. HIV/COVID‐19 co‐infection might have negatively influenced the HIV treatment and diagnosis, which indicates the need to regularly screen HIV patients in the COVID‐19 pandemic. |
format | Online Article Text |
id | pubmed-8993621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89936212022-04-13 COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series Heidary, Mohsen Asadi, Arezoo Noorbakhsh, Negar Dashtbin, Shirin Asadollahi, Parisa Dranbandi, Atieh Navidifar, Tahereh Ghanavati, Roya J Clin Lab Anal Review Article INTRODUCTION: Coronavirus disease 2019 (COVID‐19) and acquired immune deficiency syndrome (AIDS) are two viral diseases for which there are currently no definitive treatments. Nowadays, because of the health system's focus on the COVID‐19 epidemic, the control of human immunodeficiency virus (HIV) has received less attention. In this review, we will discuss the characteristics of COVID‐19 in HIV‐positive patients. MATERIAL AND METHODS: Using the PRISMA guideline, the databases of Scopus, PubMed, and Web of Science were searched systematically from January 1, 2019 to February 24, 2021. The following keywords were used: “Human Immunodeficiency Virus,” “acquired immune deficiency syndrome,” “HIV,” “AIDS,” “COVID‐19,” “severe acute respiratory syndrome coronavirus 2,” “novel coronavirus,” “SARS‐CoV‐2,” “nCoV disease,” “SARS2,” and “2019‐nCoV disease.” RESULTS: Twenty‐one percent of studies were conducted in the USA (n = 13), 16% in China (n = 10), and 13% in Italy (n = 8), respectively. The majority of the patients were men (74.3%). Tenofovir disoproxil fumarate was used in 47.4% of patients, emtricitabine in 58.4%, and lamivudine in 34.8% to treat HIV. Symptoms of HIV patients with COVID‐19 included coughing (81.3%), fever (62.8%), and dyspnea (60%). Hydroxychloroquine (39.34%) and azithromycin (36.58%) were the common treatment options for COVID‐19. The total death rate in HIV‐positive patients with COVID‐19 was about 9%. CONCLUSION: In the current systematic review, we demonstrated that HIV‐positive patients co‐infected with COVID‐19 have high comorbidity of hypertension and diabetes mellitus. HIV/COVID‐19 co‐infection might have negatively influenced the HIV treatment and diagnosis, which indicates the need to regularly screen HIV patients in the COVID‐19 pandemic. John Wiley and Sons Inc. 2022-02-20 /pmc/articles/PMC8993621/ /pubmed/35187723 http://dx.doi.org/10.1002/jcla.24308 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Heidary, Mohsen Asadi, Arezoo Noorbakhsh, Negar Dashtbin, Shirin Asadollahi, Parisa Dranbandi, Atieh Navidifar, Tahereh Ghanavati, Roya COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series |
title | COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series |
title_full | COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series |
title_fullStr | COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series |
title_full_unstemmed | COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series |
title_short | COVID‐19 in HIV‐positive patients: A systematic review of case reports and case series |
title_sort | covid‐19 in hiv‐positive patients: a systematic review of case reports and case series |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993621/ https://www.ncbi.nlm.nih.gov/pubmed/35187723 http://dx.doi.org/10.1002/jcla.24308 |
work_keys_str_mv | AT heidarymohsen covid19inhivpositivepatientsasystematicreviewofcasereportsandcaseseries AT asadiarezoo covid19inhivpositivepatientsasystematicreviewofcasereportsandcaseseries AT noorbakhshnegar covid19inhivpositivepatientsasystematicreviewofcasereportsandcaseseries AT dashtbinshirin covid19inhivpositivepatientsasystematicreviewofcasereportsandcaseseries AT asadollahiparisa covid19inhivpositivepatientsasystematicreviewofcasereportsandcaseseries AT dranbandiatieh covid19inhivpositivepatientsasystematicreviewofcasereportsandcaseseries AT navidifartahereh covid19inhivpositivepatientsasystematicreviewofcasereportsandcaseseries AT ghanavatiroya covid19inhivpositivepatientsasystematicreviewofcasereportsandcaseseries |